Page last updated: 2024-11-06

mitomycin and Coronary Restenosis

mitomycin has been researched along with Coronary Restenosis in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Research Excerpts

ExcerptRelevanceReference
"GES treated with mitomycin C can significantly inhibit neointimal formation in rabbit arteries due to the formation of granulation tissue."1.34Granulation encapsulated stent: a new therapeutic approach for vascular implantation. ( Chen, X; Gardin, JM; LaLonde, T; Tang, L; Tang, S, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, L1
Chen, X1
Tang, S1
LaLonde, T1
Gardin, JM1

Other Studies

1 other study available for mitomycin and Coronary Restenosis

ArticleYear
Granulation encapsulated stent: a new therapeutic approach for vascular implantation.
    Heart (British Cardiac Society), 2007, Volume: 93, Issue:2

    Topics: Animals; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Granulation Tissue; Granuloma, F

2007